Fresenius

We just published our full year results for 2023 in advance of the press conference. Fresenius closed FY/23 with a strong fourth quarter driven by the performance of Fresenius Kabi and Fresenius Helios, and Vamed's ongoing improvements. 📈 fresenius.com/node/6788

Fresenius signs Zero Health Gaps Pledge to promote equal opportunities in healthcare fresenius.com/node/6767 Fresenius unterzeichnet „Zero Health Gaps“ Verpflichtung zur Förderung der Chancengleichheit in der Gesundheitsversorgung fresenius.com/de/node/6767

Happy New Year to you and your loved ones! Our best wishes for a year full of health, happiness, and new opportunities. #HappyNewYear #Fresenius

Wishing a Merry Christmas to all celebrating! 🎄❄️ May this holiday season be filled with laughter, joy, and cherished moments with loved ones. As the year comes to an end, we extend our sincere appreciation for your ongoing support. #MerryChristmas #HappyHolidays #Fresenius

Fresenius Helios strengthens operational focus in digitalization fresenius.com/node/6755 Fresenius Helios verstärkt operativen Fokus bei der Digitalisierung fresenius.com/de/node/6755

Fresenius successfully completes deconsolidation of Fresenius Medical Care (@FMC_AG) fresenius.com/node/6747 Fresenius schließt Dekonsolidierung von Fresenius Medical Care (@FMC_AG) erfolgreich ab fresenius.com/de/node/6747

Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised fresenius.com/node/6743

Fresenius Medical Care (@FMC_AG) schließt vorteilhaften Vergleich mit der U.S.-Regierung mit einem positiven Ergebniseffekt von rund 175 Mio. Euro – Ergebnisausblick für 2023 erhöht fresenius.com/de/node/6743

Today, we celebrate the birthday of our esteemed founder, the late Dr. Eduard Fresenius. 🎈 In 1912, he laid the foundation for our global healthcare group by establishing the pharmaceutical company Dr. E. Fresenius in the back of his pharmacy. #Fresenius #HappyBirthday

Fresenius sharpens focus & sells fertility services group Eugin to consortium led by KKR portfolio company IVI RMA fresenius.com/node/6733

Fresenius schärft Fokus und verkauft Reproduktionsmedizingruppe Eugin an Konsortium um KKR-Portfoliounternehmen IVI RMA fresenius.com/de/node/6733

#FutureFresenius continues to provide positive momentum: Fresenius delivers strong third quarter performance and improves operating earnings outlook fresenius.com/node/6726

#FutureFresenius sorgt weiter für positive Dynamik: Fresenius mit starker Entwicklung im dritten Quartal und verbessertem operativen Ergebnisausblick fresenius.com/de/node/6726

Fresenius Medical Care (@FMC_AG) continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter hwww.fresenius.com/node/6727

Fresenius Medical Care (@FMC_AG) setzt Turnaround-Plan um und erhöht die Gewinnprognose für 2023 aufgrund starker operativer Leistung in den ersten neun Monaten und solider Geschäftsaussichten für das vierte Quartal fresenius.com/de/node/6727

Fresenius Medical Care (@FMC_AG) appoints Craig Cordola as new Management Board member for Care Delivery fresenius.com/node/6723 Fresenius Medical Care ernennt Craig Cordola zum neuen Vorstandsmitglied für das globale Dienstleistungsgeschäft Care Delivery fresenius.com/de/node/6723

Fresenius Medical Care (@FMC_AG) Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023 fresenius.com/node/6722

Fresenius exits hospital market in Peru 🇵🇪 fresenius.com/node/6720 Fresenius steigt aus peruanischem 🇵🇪 Krankenhausmarkt aus fresenius.com/de/node/6720

Fresenius Medical Care (@FMC_AG) Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical Dataset fresenius.com/node/6718